James Michael O'Brien Insider Profile
4 Followers
James Michael O'Brien, CFO at Cognition Therapeutics, holds 5.00K shares in Cognition Therapeutics (Ticker: CGTX), holds 28.19K shares in Enzo Biochem (Ticker: ENZB). Most recently, James Michael O'Brien Bought ― shares of Cognition Therapeutics on Oct 14, 2021 for an estimated value of $60.00K.
James Michael O'Brien's Trading History
| CGTXCognition Therapeutics | Oct 14, 2021 | CFO | Informative Buy | 60.00K | $3.40K | |
| ENZBEnzo Biochem | Oct 30, 2017 | ― | Uninformative Buy | 81.62K | $19.67K |
You May Also Like
James Michael O'Brien insider profile FAQ
What is the percentage of profitable transactions made by James Michael O'Brien?
The percentage of profitable transactions made by James Michael O'Brien is 67%.
What is the average return per transaction made by James Michael O'Brien?
The average return per transaction made by James Michael O'Brien is 9.80%.
What stocks does James Michael O'Brien hold?
James Michael O'Brien holds: CGTX, ENZB stocks.
What was James Michael O'Brien’s latest transaction?
James Michael O'Brien’s latest transaction was an Informative Buy of $60.00K.
What was James Michael O'Brien's most profitable transaction?
James Michael O'Brien’s most profitable transaction was an Informative Sell of ENZB stock on October 30, 2017. The return on the trade was 67.40%.
What is James Michael O'Brien's role in Cognition Therapeutics?
James Michael O'Brien's role in Cognition Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
